Published in Semin Liver Dis on August 01, 2001
Liver fibrosis. J Clin Invest (2005) 17.27
Hepatic stellate cells: protean, multifunctional, and enigmatic cells of the liver. Physiol Rev (2008) 10.28
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ. J Clin Invest (2007) 4.41
The pancreatic stellate cell: a star on the rise in pancreatic diseases. J Clin Invest (2007) 3.39
A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell (2013) 2.58
Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development. Hepatology (2009) 2.51
Retinoid absorption and storage is impaired in mice lacking lecithin:retinol acyltransferase (LRAT). J Biol Chem (2005) 2.28
A novel mouse model of depletion of stellate cells clarifies their role in ischemia/reperfusion- and endotoxin-induced acute liver injury. J Hepatol (2013) 2.08
Vitamin A metabolism: an update. Nutrients (2011) 1.99
Hepatic stellate cell lipid droplets: a specialized lipid droplet for retinoid storage. Biochim Biophys Acta (2008) 1.89
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension. Gut (2002) 1.82
Immune surveillance by the liver. Nat Immunol (2013) 1.79
Imaging of neutral lipids by oil red O for analyzing the metabolic status in health and disease. Nat Protoc (2013) 1.72
Interleukin-1 participates in the progression from liver injury to fibrosis. Am J Physiol Gastrointest Liver Physiol (2009) 1.72
Anti-fibrogenic strategies and the regression of fibrosis. Best Pract Res Clin Gastroenterol (2011) 1.70
What's new in liver fibrosis? The origin of myofibroblasts in liver fibrosis. J Gastroenterol Hepatol (2012) 1.50
Organotypic liver culture models: meeting current challenges in toxicity testing. Crit Rev Toxicol (2012) 1.46
Hepatic tumor-stroma crosstalk guides epithelial to mesenchymal transition at the tumor edge. Oncogene (2009) 1.43
A novel murine model to deplete hepatic stellate cells uncovers their role in amplifying liver damage in mice. Hepatology (2013) 1.27
Matrix metalloproteinases, the pros and cons, in liver fibrosis. J Gastroenterol Hepatol (2006) 1.27
A matrix metalloproteinase-9 activation cascade by hepatic stellate cells in trans-differentiation in the three-dimensional extracellular matrix. J Biol Chem (2007) 1.26
Hepatic stellate cells function as regulatory bystanders. J Immunol (2011) 1.24
Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential. Hepatology (2009) 1.23
Evolving concepts of liver fibrogenesis provide new diagnostic and therapeutic options. Comp Hepatol (2007) 1.22
Retinol and retinyl esters: biochemistry and physiology. J Lipid Res (2013) 1.19
Hepatic metabolism of retinoids and disease associations. Biochim Biophys Acta (2011) 1.13
Epigenetic repression of matrix metalloproteinases in myofibroblastic hepatic stellate cells through histone deacetylases 4: implication in tissue fibrosis. Am J Pathol (2010) 1.11
Identification of vitamin A-free cells in a stellate cell-enriched fraction of normal rat liver as myofibroblasts. Histochem Cell Biol (2006) 1.08
Biomarkers of hepatic fibrosis, fibrogenesis and genetic pre-disposition pending between fiction and reality. J Cell Mol Med (2007) 1.07
Liver fibrosis: mechanisms of immune-mediated liver injury. Cell Mol Immunol (2011) 1.06
Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma. J Cancer Res Clin Oncol (2007) 1.06
Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function? J Cell Mol Med (2007) 1.06
Origin of myofibroblasts in liver fibrosis. Fibrogenesis Tissue Repair (2012) 1.05
The Necdin-Wnt pathway causes epigenetic peroxisome proliferator-activated receptor gamma repression in hepatic stellate cells. J Biol Chem (2010) 1.05
Cellular organization of normal mouse liver: a histological, quantitative immunocytochemical, and fine structural analysis. Histochem Cell Biol (2009) 1.05
Recent advances in the pathogenesis and diagnosis of liver fibrosis. J Gastroenterol (2008) 1.02
Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am J Pathol (2003) 1.02
Rosmarinic acid and baicalin epigenetically derepress peroxisomal proliferator-activated receptor γ in hepatic stellate cells for their antifibrotic effect. Hepatology (2012) 1.01
Hepatic stellate cells--the pericytes in the liver. Pflugers Arch (2013) 1.01
The types of hepatic myofibroblasts contributing to liver fibrosis of different etiologies. Front Pharmacol (2014) 1.01
Ductal plates in hepatic ductular reactions. Hypothesis and implications. I. Types of ductular reaction reconsidered. Virchows Arch (2011) 0.99
Intermediate filament cytoskeleton of the liver in health and disease. Histochem Cell Biol (2008) 0.99
Cell signals influencing hepatic fibrosis. Int J Hepatol (2012) 0.98
Class II HDAC inhibition hampers hepatic stellate cell activation by induction of microRNA-29. PLoS One (2013) 0.98
Gene expression profiles of hepatic cell-type specific marker genes in progression of liver fibrosis. World J Gastroenterol (2006) 0.97
Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update. World J Gastroenterol (2014) 0.97
HDAC inhibitors in experimental liver and kidney fibrosis. Fibrogenesis Tissue Repair (2013) 0.96
Selective expansion of allogeneic regulatory T cells by hepatic stellate cells: role of endotoxin and implications for allograft tolerance. J Immunol (2012) 0.96
Blebbistatin inhibits contraction and accelerates migration in mouse hepatic stellate cells. Br J Pharmacol (2009) 0.96
Reciprocal modulation of matrix metalloproteinase-13 and type I collagen genes in rat hepatic stellate cells. Am J Pathol (2003) 0.96
Histochemical analyses of living mouse liver under different hemodynamic conditions by "in vivo cryotechnique". Histochem Cell Biol (2006) 0.94
Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol (2015) 0.94
Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule. Am J Pathol (2007) 0.93
Liver fibrogenesis due to cholestasis is associated with increased Smad7 expression and Smad3 signaling. J Cell Mol Med (2006) 0.93
Role of cannabinoids in chronic liver diseases. World J Gastroenterol (2008) 0.93
Seven steps to stellate cells. J Vis Exp (2011) 0.92
Hepatic stellate cells express synemin, a protein bridging intermediate filaments to focal adhesions. Gut (2006) 0.92
Hepatic stellate cells undermine the allostimulatory function of liver myeloid dendritic cells via STAT3-dependent induction of IDO. J Immunol (2012) 0.92
Hepatic stellate cell progenitor cells. J Gastroenterol Hepatol (2012) 0.92
Nrf2 and Snail-1 in the prevention of experimental liver fibrosis by caffeine. World J Gastroenterol (2013) 0.91
Noninvasive tools to assess hepatic fibrosis: ready for prime time? Gastroenterol Clin North Am (2011) 0.91
Morphogens and hepatic stellate cell fate regulation in chronic liver disease. J Gastroenterol Hepatol (2012) 0.91
PTK787/ZK22258 attenuates stellate cell activation and hepatic fibrosis in vivo by inhibiting VEGF signaling. Lab Invest (2008) 0.91
Growth arrest and decrease of alpha-SMA and type I collagen expression by palmitic acid in the rat hepatic stellate cell line PAV-1. Dig Dis Sci (2006) 0.90
Evidence for a common progenitor of epithelial and mesenchymal components of the liver. Cell Death Differ (2013) 0.90
Multilayered heparin hydrogel microwells for cultivation of primary hepatocytes. Adv Healthc Mater (2013) 0.89
Vascular endothelial growth factor and angiopoietins regulate sinusoidal regeneration and remodeling after partial hepatectomy in rats. World J Gastroenterol (2005) 0.89
Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr (2014) 0.89
Cellular and molecular functions of hepatic stellate cells in inflammatory responses and liver immunology. Hepatobiliary Surg Nutr (2014) 0.88
Changes in growth factor and cytokine expression in biliary obstructed rat liver and their relationship with delayed liver regeneration after partial hepatectomy. World J Gastroenterol (2006) 0.88
Role of the receptor for advanced glycation end products in hepatic fibrosis. World J Gastroenterol (2009) 0.88
The multifaceted nature of retinoid transport and metabolism. Hepatobiliary Surg Nutr (2014) 0.87
Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells. Br J Pharmacol (2005) 0.87
Fibrogenic cell reversion underlies fibrosis regression in liver. Proc Natl Acad Sci U S A (2012) 0.87
Reversibility of liver fibrosis. Clin Res Hepatol Gastroenterol (2015) 0.86
Oxidized low-density-lipoprotein accumulation is associated with liver fibrosis in experimental cholestasis. Clinics (Sao Paulo) (2008) 0.86
Switch of cadherin expression from E- to N-type during the activation of rat hepatic stellate cells. Histochem Cell Biol (2006) 0.86
Membrane-to-Nucleus Signals and Epigenetic Mechanisms for Myofibroblastic Activation and Desmoplastic Stroma: Potential Therapeutic Targets for Liver Metastasis? Mol Cancer Res (2014) 0.86
Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome. Int J Mol Sci (2016) 0.86
Value of α-smooth muscle actin and glial fibrillary acidic protein in predicting early hepatic fibrosis in chronic hepatitis C virus infection. Arch Med Sci (2010) 0.85
Retinyl ester hydrolases and their roles in vitamin A homeostasis. Biochim Biophys Acta (2011) 0.85
Non-invasive diagnosis of liver fibrosis and cirrhosis. World J Gastroenterol (2015) 0.84
Natural Killer Cells and Liver Fibrosis. Front Immunol (2016) 0.84
Hepatic Stellate Cells and microRNAs in Pathogenesis of Liver Fibrosis. J Clin Med (2016) 0.84
Fucoidan partly prevents CCl4-induced liver fibrosis. Eur J Pharmacol (2007) 0.84
Retinoic acid inducible gene-I (RIG-I) signaling of hepatic stellate cells inhibits hepatitis C virus replication in hepatocytes. Innate Immun (2012) 0.84
Gliotoxin ameliorates development of fibrosis and cirrhosis in a thioacetamide rat model. Dig Dis Sci (2003) 0.84
Increased liver uptake and reduced hepatic stellate cell activation with a cell-specific conjugate of the Rho-kinase inhibitor Y27632. Pharm Res (2011) 0.84
Effect of sea buckthorn on liver fibrosis: a clinical study. World J Gastroenterol (2003) 0.83
Vitamin a deficiency and alterations in the extracellular matrix. Nutrients (2014) 0.82
Hepatic stellate cells and astrocytes: Stars of scar formation and tissue repair. Cell Cycle (2011) 0.82
Induction of interferon-λ contributes to Toll-like receptor-3-activated hepatic stellate cell-mediated hepatitis C virus inhibition in hepatocytes. J Viral Hepat (2013) 0.82
Expression of angiotensinogen during hepatic fibrogenesis and its effect on hepatic stellate cells. Med Sci Monit (2011) 0.82
A peroxisome-proliferator activated receptor-gamma ligand could regulate the expression of leptin receptor on human hepatic stellate cells. Histochem Cell Biol (2007) 0.82
Genetic characteristics of the human hepatic stellate cell line LX-2. PLoS One (2013) 0.81
Immunohistochemical study of the phenotypic change of the mesenchymal cells during portal tract maturation in normal and fibrous (ductal plate malformation) fetal liver. Comp Hepatol (2009) 0.81
N-terminal region of gelsolin induces apoptosis of activated hepatic stellate cells by a caspase-dependent mechanism. PLoS One (2012) 0.80
Identification of markers for quiescent pancreatic stellate cells in the normal human pancreas. Histochem Cell Biol (2017) 0.80
Segmental cholangitis impairs hepatic regeneration capacity after partial hepatectomy in rats. HPB (Oxford) (2010) 0.80
Hepatic stellate cells are involved in the pathogenesis of acute-on-chronic liver failure (ACLF). Virchows Arch (2012) 0.80